| CAS ID: | 10118-90-8 |
| Molecular Formula: | C23H27N3O7 |
| Molecular Weight: | 457.5 g/mol |
| Monoisotopic Mass: | 457.1849 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | DYNACIN | DENTOMYCIN | SEBOMIN | SEBREN MR | BLEMIX 100 | XIMINO | MINOLIRA | AKNEMIN 50 | MINOCIN MR | MINOCYCLINE | MINOCIN | BLEMIX 50 | ARESTIN | AKNEMIN | ACNAMINO | SOLODYN | MINOCIN 50 | MINOCYCLINE HYDROCHLORIDE | CYCLOMIN | MINOGAL |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C23H27N3O7/c1-25(2)12-5-6-13(27)15-10(12)7-9-8-11-17(26(3)4)19(29)16(22(24)32)21(31)23(11,33)20(30)14(9)18(15)28/h5-6,9,11,17,27,29-30,33H,7-8H2,1-4H3,(H2,24,32)/t9-,11-,17-,23-/m0/s1 | See All |
| InChI Key: | DYKFCLLONBREIL-KVUCHLLUSA-N | |
| Smiles: | CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(ccc(O)c4C(=O)C3=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N)N(C)C | See All |
| Molfile: |
Trial Record 1
| ClinicalTrial ID | NCT00203697 | Disease | Idiopathic pulmonary fibrosis |
| Phase | Phase 3 | Status | Unknown |
| First Received | September 20, 2005 | Last Verified | September 11, 2006 |
| Sponsor | University of California, Los Angeles | ||
Trial Record 2
| ClinicalTrial ID | NCT01349192 | Disease | Cystic fibrosis |
| Phase | Phase 2 | Status | Terminated |
| First Received | May 6, 2011 | Last Verified | May 15, 2017 |
| Sponsor | University of North Carolina, Chapel Hill | ||
| PubChem: | 54675783 |
| ChEMBL: | CHEMBL1434 |